EIAS predominantly occurs in individuals with diabetes undergoing insulin therapy, particularly associated with specific insulin formulations and genetic predispositions (e.g., certain HLA genotypes) (1, 2).Diagnosis relies on the detection of insulin autoantibodies and observation of characteristic blood glucose fluctuations, requiring differentiation from other conditions such as insulinoma or factitious hypoglycemia. This evidence concerns the gene INS and diabetes mellitus.